.

.


LogOff Samples
The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. Antibiotic susceptibility of potentially probiotic Lactobacillus species.
    Journal of food protection (J Food Prot ) Vol: 61 Issue 12 Pages: 1636-43
    Pub: 1998 Dec Epub:
    • Charteris WP
    • Kelly PM
    • Morelli L
    • Collins JK

  2. The antimicrobial resistance pattern of cultured human methanogens reflects the unique phylogenetic position of archaea.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 66 Issue 9 Pages: 2038-44
    Pub: 2011 Sep Epub: 2011 Jun 16
    • Dridi B
    • Fardeau ML
    • Ollivier B
    • Raoult D
    • Drancourt M

  3. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach
    Clinical and Experimental Gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 309-325
    Pub: 2015 Dec 4 Epub: 2015 Dec 4
    • Soldi S
    • Vasileiadis S
    • Uggeri F
    • Campanale M
    • Morelli L
    • Fogli MV
    • Calanni F
    • Grimaldi M
    • Gasbarrini A

  4. Antibiotic susceptibility profiles of new probiotic Lactobacillus and Bifidobacterium strains.
    International journal of food microbiology (Int J Food Microbiol ) Vol: 98 Issue 2 Pages: 211-7
    Pub: 2005 Feb 1 Epub:
    • Zhou JS
    • Pillidge CJ
    • Gopal PK
    • Gill HS

  5. Antibiotic susceptibility of potentially probiotic Bifidobacterium isolates from the human gastrointestinal tract.
    Letters in applied microbiology (Lett Appl Microbiol ) Vol: 26 Issue 5 Pages: 333-7
    Pub: 1998 May Epub:
    • Charteris WP
    • Kelly PM
    • Morelli L
    • Collins JK

  6. Extensive impact of non-antibiotic drugs on human gut bacteria.
    Nature (Nature ) Vol: 555 Issue 7698 Pages: 623-628
    Pub: 2018 Mar 29 Epub: 2018 Mar 19
    • Maier L
    • Pruteanu M
    • Kuhn M
    • Zeller G
    • Telzerow A
    • Anderson EE
    • Brochado AR
    • Fernandez KC
    • Dose H
    • Mori H
    • Patil KR
    • Bork P
    • Typas A

  7. Additional sources and private correspondance
    Private Correspondance (Private Correspondance ) Vol: 1 Issue Pages: 8-12
    Pub: 2018 Epub:
  8. Rifaximin ameliorates hepatic encephalopathy and endotoxemia without affecting the gut microbiome diversity.
    World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 47 Pages: 8355-8366
    Pub: 2017 Dec 21 Epub:
    • Kaji K
    • Takaya H
    • Saikawa S
    • Furukawa M
    • Sato S
    • Kawaratani H
    • Kitade M
    • Moriya K
    • Namisaki T
    • Akahane T
    • Mitoro A
    • Yoshiji H

  9. Rifaximin modulates the colonic microbiota of patients with Crohn`s disease: an in vitro approach using a continuous culture colonic model system.
    The Journal of antimicrobial chemotherapy (J Antimicrob Chemother ) Vol: 65 Issue 12 Pages: 2556-65
    Pub: 2010 Dec Epub: 2010 Sep 18
    • Maccaferri S
    • Vitali B
    • Klinder A
    • Kolida S
    • Ndagijimana M
    • Laghi L
    • Calanni F
    • Brigidi P
    • Gibson GR
    • Costabile A

  10. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
    PloS one (PLoS One ) Vol: 8 Issue 4 Pages: e60042
    Pub: 2013 Epub: 2013 Apr 2
    • Bajaj JS
    • Heuman DM
    • Sanyal AJ
    • Hylemon PB
    • Sterling RK
    • Stravitz RT
    • Fuchs M
    • Ridlon JM
    • Daita K
    • Monteith P
    • Noble NA
    • White MB
    • Fisher A
    • Sikaroodi M
    • Rangwala H
    • Gillevet PM

Full list available by paid subscriptions

For More information see this summary.